V
Vor Biopharma Inc. (VOR)
NMS – Real Time Price. Currency in USD
16.10
+1.17 (7.84%)
At close: Jun 26, 2026, 4:00 PM EDT
15.27
-0.83 (-5.16%)
After-hours: Jun 26, 2026, 7:40 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
16.10
+1.17 (7.84%)
At close: Jun 26, 2026, 4:00 PM EDT
15.27
-0.83 (-5.16%)
After-hours: Jun 26, 2026, 7:40 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $169.9M significantly exceed its total debt $2.9M, ensuring strong financial flexibility
Total current assets $500.8M exceed Total current liabilities $16.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$38.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 31.15 | 6.05 | 10 | |
| Quick ratio | 31.15 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -9M | -3M | -4M | -3M | -2M |
| Operating Income | -93M | -126M | -121M | -372M | -374M |
| Net Income | -92M | -118M | -117M | -696M | -883M |
| EBITDA | -84M | -123M | -118M | -369M | -371M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 99.72 | 5.5 |
| Next quarter | N/A | 99.38 | 5.5 |
| Current year | N/A | 90.78 | 5.5 |
| Next year | N/A | 46.39 | 5.5 |
| Weighted average score | 5.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -112.74 | -111.47 | -65.66 | 3.3 |
| Y/Y | 999 | -575.93 | 1.73 | -22.35 | 3.8 |
| 3y average | 999 | -174.14 | -26.52 | -16.86 | 3.3 |
| 5y average | 999 | -123 | 1.7 | -31.85 | 3.8 |
| Weighted average score | 3.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |